Lightnews — Scholar-powered news

Great Debates

@greatdebates.bsky.social

61 followers 260 following 69 posts

Great Debates hosts expert-led events tackling key issues in oncology. GD Solid Tumors focuses on emerging therapies for solid tumors, while GD Hematologic Malignancies highlights innovations in blood cancer care. Learn More: hmpglobalevents.com/gdu

Posts Media Videos Starter Packs

Pinned

Great Debates @greatdebates.bsky.social · Apr 1

How are advancements shaping oncology and hematology? Join the Great Debates series to hear experts tackle clinical controversies, explore new treatments, and elevate patient care. #GreatDebates #Oncology #Hematology

Great Debates @greatdebates.bsky.social · 20d

Every debate, every decision, every treatment option in oncology begins with research.

This #WorldCancerResearchDay, we honor the ongoing work that fuels innovation and improves outcomes for patients everywhere.

#CancerResearch #Oncology #MedicalEducation #GreatDebates

Reposted by Great Debates

MSK Department of Medicine @mskdeptofmed.bsky.social · Sep 13

Starting TODAY! Join @greatdebates.bsky.social
and Yelena Janjigian, Chief of the MSK Gastrointestinal Oncology Service, to learn about the latest treatments for #gastriccancer and #colorectalcancer.

@mskcancercenter.bsky.social #crcsm #GIcancer

See the full agenda 📖: bit.ly/48g13pf

2 2

Great Debates @greatdebates.bsky.social · Aug 5

Faculty from Sylvester Cancer Center will join us at Great Debates in Solid Tumors this September.

Drs. Lopes, Merchant, Paluvoi, and @latinamd.bsky.social bring the insight. Miami brings the view.

Sept 13–14 | gdsolidtumors.com

#GDST25 #Oncology #MedicalEducation

Great Debates @greatdebates.bsky.social · Jul 18

Interested in joining us? Visit gdhematology.com for more info.

Great Debates @greatdebates.bsky.social · Jul 18

You're making treatment decisions every day. But who’s helping you weigh the latest data, options, and gray areas in hematologic care?

Join a room full of engaged clinicians and expert voices who don’t just present the data—they challenge it.

#GDHEM #Oncology #Hematology #CancerCare

Great Debates @greatdebates.bsky.social · Jul 11

Is it time to move away from transplant in myeloma?

Dr. Rafael Fonseca and Dr. Andrew Cowan will debate the role of ASCT in today’s evolving treatment landscape.

www.gdhematology.com

#GDHEM

Great Debates @greatdebates.bsky.social · Jul 9

Dr. Ami Neghandi shares why Great Debates in Solid Tumors stands out. From the smaller setting to the clinically focused debates, it offers something different. Hear her perspective and see why you should join us on Sept 13-14.

Learn More: gdsolidtumors.com
#GDST #MedicalEducation #Cancer #Oncology

Great Debates @greatdebates.bsky.social · Jul 8

BTK or BCL-2? The evidence continues to evolve, and with it, treatment decisions in CLL. In this session at #GDHEM, Dr. Catherine Coombs reviews the latest data on sequencing strategies, real-world AE management, and the role of MRD and molecular profiling in guiding care.

www.gdhematology.com

Great Debates @greatdebates.bsky.social · Jul 7

GEJ cancer treatment planning isn’t always clear-cut.

At #GDST, Drs. Biachi and Uboha debate neoadjuvant vs adjuvant strategies—downstaging, recurrence risk, and the role of ctDNA in refining decisions.

Learn more: www.hmpglobalevents.com/gdst

#GEJcancer #Oncology #CancerResearch

Great Debates @greatdebates.bsky.social · Jul 1

Are ICIs more impactful in locally advanced cervical cancer—or in the first-line metastatic setting with chemo? At #GDST, Drs. Leath and Duska will debate timing, trial data, & patient-specific impact.

Join us in virtually or in Miami this September: gdsolidtumors.com

#CervicalCancer #WomensHealth

Great Debates @greatdebates.bsky.social · Jun 24

CTLA-4 inhibitors aren’t standard in NSCLC but could that change? At #GDST, Drs. Rodriguez and Raez debate the potential role of CTLA-4 inhibition in lung cancer treatment today.

Join us in Miami or virtually this September.
Learn more: gdsolidtumors.com
#LungCancer #NSCLC #Immunotherapy #Oncology

Great Debates @greatdebates.bsky.social · Jun 23

Still time to register for #GDHEM this month in NYC.

Leaders in leukemia, lymphoma & myeloma will debate today’s most pressing treatment questions—so you leave with strategies that translate to clinic.

📍 June 28–29 | InterContinental Times Square
🔗 gdhematology.com

#MedicalEducation #CancerCare

Great Debates @greatdebates.bsky.social · Jun 19

What’s next for low- and intermediate-risk MDS?

Dr. Aditi Shastri joins us in New York City this month to talk symptom control, PROMs, and tailoring care for real patients—not just protocols.

🔗 gdhematology.com

#MDS #Hematology #Oncology #CancerCare

Great Debates @greatdebates.bsky.social · Jun 18

@mskcancercenter.bsky.social

Great Debates @greatdebates.bsky.social · Jun 18

Frontline treatment in advanced HCC continues to evolve.

At #GDST, Drs. Harding and Alese will debate VEGF inhibition + ICI vs dual checkpoint blockade—exploring efficacy, sequencing, and patient selection.

Join us for this pressing debate: www.hmpglobalevents.com/gdst

#HCC #CancerCancer

Great Debates @greatdebates.bsky.social · Jun 17

@weillcornell.bsky.social

Great Debates @greatdebates.bsky.social · Jun 17

First-line treatment in #DLBCL is evolving—fast.

At #GDHEM, Dr. Sarah Rutherford reviews new frontline strategies, key trial data, and where care is headed for high-risk patients.

Join us this month in New York City. Learn more at gdhematology.com

#Lymphoma #Hematology #Oncology #ClinicalTrials

Great Debates @greatdebates.bsky.social · Jun 14

We’re heading to NYC this month for #GDHEM and proud to feature this outstanding group of faculty from across New York and New Jersey.

Wondering how your peers are tackling the toughest questions in hematology? Join the conversation.
🔗 gdhematology.com

#MedicalEducation #Oncology #Hematology

Great Debates @greatdebates.bsky.social · Jun 14

What if we treated by target, not tissue?

At #GDST, Dr. David Hong explores the future of tumor-agnostic therapies—molecular drivers, AI, and what it means for precision oncology.

Join us this September in Miami or virtually: www.hmpglobalevents.com/gdst

#TargetedTherapy #Oncology #CancerCare

Great Debates @greatdebates.bsky.social · Jun 10

Frontline myeloma care is changing fast.

At #GDHEM, Dr. @jmikhaelmd.bsky.social breaks down the shift to quadruplets, recent FDA approvals, and what’s next for transplant-eligible and ineligible patients.

Join us in NYC: gdhematology.com

#Myeloma #Hematology #Oncology ‪@cityofhope.bsky.social‬

Great Debates @greatdebates.bsky.social · Jun 9

Earlier use of novel endocrine therapies in HR+ breast cancer: do they make a difference here?

Join Drs. Wander and Gandhi at #GDST as they debate the evidence, uncertainty, and impact of rethinking treatment lines.

📅 Sept 13–14
🔗 www.hmpglobalevents.com/gdst

#BreastCancer #Oncology #bcsm

Great Debates @greatdebates.bsky.social · Jun 5

On #NationalCancerSurvivorsDay, we recognize the strength, persistence, and presence of cancer survivors everywhere.

Your experiences continue to shape the future of care and support.

#CancerSurvivorship #Oncology

Great Debates @greatdebates.bsky.social · Jun 4

📣 Meet the Florida-based experts shaping this year’s #GDST!

Drs. Tiago Biachi, Gilberto Lopes, Nipun Merchant, Luis Raez, and ‪@latinamd.bsky.social‬ will join the debate-driven faculty lineup in Miami this September.

Learn more: hubs.ly/Q03qLVx30

#MedicalEducation #CancerCare #Oncology

1 1

Great Debates @greatdebates.bsky.social · Jun 2

📣 Meet the Co-Chairs for #GDHEM!

Drs. Jessica K. Altman, @johnpleonardmd.bsky.social‬, @jmikhaelmd.bsky.social are shaping a dynamic program that will tackle evolving standards and real-world decision-making in #hematology.

Learn more: gdhematology.com

#Oncology #Leukemia #Lymphoma #Myeloma

Great Debates @greatdebates.bsky.social · May 28

🩸 Every 27 seconds, someone in the world is diagnosed.

On #WorldBloodCancerDay, we recognize how quickly a life can change. Blood donors are critical in the treatment of #leukemia, #lymphoma, #myeloma, and other #bloodcancers. If you're able, consider #BloodDonation and being part of that change.